Skip to main content
. 2020 Jan 7;6(3):290–298. doi: 10.1002/vms3.232

Table 1.

Demographic data and treatment groups

Gender Age (years)
Male Female 6–8 9–12 13–16
15 (34.1%) 29 (65.9%) 19 (43.3%) 18 (40.9%) 7 (15.9%)
  n %
Breed
Crossbreed 8 18.2
German Boxer 3 6.8
American Staffordshire Terrier 3 6.8
Beagle 2 4.5
West Highland White Terrier 2 4.5
Cocker Spaniel 2 4.5
French Bulldog 2 4.5
Greyhound 2 4.5
Boston Terrier 2 4.5
Miniature Schnauzer 1 2.3
Bull Terrier 1 2.3
Jack Russell Terrier 1 2.3
Jagdterrier 1 2.3
Berger Blanc Suisse 1 2.3
Pug 1 2.3
Golden Retriever 1 2.3
Maltese Dog 1 2.3
English Setter 1 2.3
Bloodhound 1 2.3
Bernese Mountain Dog 1 2.3
Flat‐Coated Retriever 1 2.3
Staffordshire Bull Terrier 1 2.3
Alaskan Malamute 1 2.3
Shetland Sheepdog 1 2.3
Soft Coated Wheaten Terrier 1 2.3
Basset Hound 1 2.3
Weimeraner 1 2.3
Type of tumour
Mast cell tumour 30 68.2
Oral malignant melanoma 4 9.1
Plasma cell tumour 2 4.5
Oral fibrosarcoma 2 4.5
Neurofibrosarcoma 2 4.5
Soft tissue sarcoma 1 2.3
Histiocytic sarcoma 1 2.3
Squamous cell carcinoma 1 2.3
Fibrosarcoma 1 2.3
Type of treatment
ECT + GET 27 61.4
Surgery + ECT + GET 8 18.2
GET 4 9.1
ECT 2 4.5
Surgery + GET 2 4.5
Surgery + ECT 1 2.3